SCHEMBL7367011

SCHEMBL7367011

N#Cc1cccc(NC(=O)CCCCCC(=O)C(F)(F)F)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 8/20 0.66
HDAC1 Q13547 8/20 0.66
HDAC2 Q92769 8/20 0.66
HDAC10 Q969S8 8/20 0.66
HDAC11 Q96DB2 8/20 0.66
HDAC8 Q9BY41 8/20 0.66
HDAC6 Q9UBN7 8/20 0.66
HDAC4 P56524 7/20 0.66
HDAC7 Q8WUI4 7/20 0.66
HDAC9 Q9UKV0 7/20 0.66
HDAC5 Q9UQL6 7/20 0.66
NCOR1 O75376 1/20 0.65
LMNA P02545 1/20 0.54
PDK1 Q15118 1/20 0.52
PDK2 Q15119 1/20 0.52
PDK3 Q15120 1/20 0.52
PDK4 Q16654 1/20 0.52
NCOR2 Q9Y618 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.51
KMT2A Q03164 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7371262 1.00 HDAC3 (0.66) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL7371472 0.87 HDAC1 (0.77) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL7372528 0.87 HDAC1 (0.77) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL23054775 0.84 LMNA (0.63) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL15480400 0.84 HDAC1 (0.65) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL15480392 0.83 LMNA (0.58) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL7372007 0.81 HDAC1 (0.70) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL7371465 0.81 HDAC3 (0.71) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL2702892 0.80 HDAC4 (1.00) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL7367562 0.80 HDAC1 (1.00) HDAC3HDAC1HDAC2HDAC10HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US claimed
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103192-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC4 HDAC3 6/4885HDAC1 1/4885HDAC2 7/4885
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC3 3/4885HDAC1 1/4885HDAC2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.